- Previous Close
72.04 - Open
72.23 - Bid 70.75 x 900
- Ask 71.95 x 900
- Day's Range
71.68 - 72.72 - 52 Week Range
63.45 - 81.42 - Volume
2,875,560 - Avg. Volume
3,913,256 - Market Cap (intraday)
37.916B - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
13.57 - EPS (TTM)
5.31 - Earnings Date Oct 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
86.07
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
www.centene.comRecent News: CNC
View MorePerformance Overview: CNC
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNC
View MoreValuation Measures
Market Cap
37.90B
Enterprise Value
35.31B
Trailing P/E
13.57
Forward P/E
9.63
PEG Ratio (5yr expected)
0.68
Price/Sales (ttm)
0.25
Price/Book (mrq)
1.39
Enterprise Value/Revenue
0.22
Enterprise Value/EBITDA
6.13
Financial Highlights
Profitability and Income Statement
Profit Margin
1.96%
Return on Assets (ttm)
3.78%
Return on Equity (ttm)
10.59%
Revenue (ttm)
144.06B
Net Income Avi to Common (ttm)
2.82B
Diluted EPS (ttm)
5.31
Balance Sheet and Cash Flow
Total Cash (mrq)
20.21B
Total Debt/Equity (mrq)
64.20%
Levered Free Cash Flow (ttm)
1.97B
Research Analysis: CNC
View MoreCompany Insights: CNC
CNC does not have Company Insights
Research Reports: CNC
View MoreWhile the Election Looms, Near-Term Regulatory Risks Look Manageable for Managed-Care Organizations
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
RatingPrice TargetRaising price target
Centene is an international healthcare company. Based in St. Louis, Centene offers services to government-sponsored and commercial healthcare providers, with an emphasis on underinsured and uninsured individuals. It is the largest Medicaid managed care organization in the U.S. and a leading provider of insurance under the Affordable Care Act. Its Specialty Services segment provides a range of healthcare products and services to managed care members and other customers.
RatingPrice TargetWith all things viewed in context, insider-sentiment data from Vickers Stock
With all things viewed in context, insider-sentiment data from Vickers Stock Research is 'better' this week than in other recent weeks. The sell/buy ratios from Vickers this week are indeed vastly improved over the last few weeks. The NYSE One-Week Sell/Buy Ratio is now 4.04, a big improvement from 11.00 last week and 11.87 the week before that. On the Nasdaq, the one-week reading is now 3.39 and compares very favorably with a 10.53 result recorded three weeks ago, as the Nasdaq had soured a week before the NYSE. So the trend is good, but, contextually, the ratios are still not clearly bullish - just a lot less bearish. Drilling down, the number of insider sell transactions grew higher still this week, with a 20% increase in sales compared to last week. But, in a positive offset, the number of purchase transactions also popped -- and by 161%. End of day, insiders seem less panicky than they did a few weeks ago - and that that seems to align with the mood of investors in general. But let's not forget that, in context, the S&P 500 closed last week at a level that is still 323 points below where it was in mid-July. On a sector basis, selling by insiders last week was greatest in Healthcare, with shares valued at $127 million sold versus roughly $4 million bought, followed by Information Technology, which saw nearly $90 million of shares sold. Buying outpaced selling in the Energy sector. This week, analysts at Vickers highlighted insider transactions of interest at Stryker Corp. (NYSE: SYK) and Block Inc. (NYSE: SQ).
Centene Earnings: Individual Plan Growth Offsets Medicaid Redetermination Effects
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
RatingPrice Target